Latest Breaking News On - ஷிகர் மெஹ்ரோத்ரா - Page 1 : comparemela.com

Large-scale study focuses on COVID-19 antibodies in asymptomatic and symptomatic patients MUSC Hollings Cancer Center researchers added to the understanding of the protective immune response against the SARS-CoV-2 virus in a study published in April in iScience. The team found that approximately 3% of the population is asymptomatic, which means that their bodies can get rid of the virus without developing signs of illness. The researchers screened more than 60,000 blood samples from symptomless individuals in the Southeastern U.S., including Georgia, South Carolina and North Carolina, for the IgG antibody to the viral spike protein. What began as a highly collaborative statewide effort to detect SARS-CoV-2 accurately, when tests were lacking, has led to discoveries. Last year, Shikhar Mehrotra, Ph.D., professor, and scientific director of the FACT-accredited Clean Cell Therapy Unit at MUSC, led the task of developing a method to detect COVID-19 infections rapidly in patients.

United statesNorth carolinaSouth carolinaShikhar mehrotraEmily hendersonHollings cancer centerCancer centerClean cell therapy unitClean cell facilityAfrican americanஒன்றுபட்டது மாநிலங்களில்வடக்கு கரோலினாதெற்கு கரோலினாஷிகர் மெஹ்ரோத்ராஎமிலி ஹென்டர்சன்புற்றுநோய் மையம்